[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE289991T1 - Substituierte beta-alaninen - Google Patents

Substituierte beta-alaninen

Info

Publication number
ATE289991T1
ATE289991T1 AT98962586T AT98962586T ATE289991T1 AT E289991 T1 ATE289991 T1 AT E289991T1 AT 98962586 T AT98962586 T AT 98962586T AT 98962586 T AT98962586 T AT 98962586T AT E289991 T1 ATE289991 T1 AT E289991T1
Authority
AT
Austria
Prior art keywords
compounds
alanines
prodrugs
halogen
hydrogen
Prior art date
Application number
AT98962586T
Other languages
English (en)
Inventor
Peter Charles Astles
Neil Victor Harris
Andrew David Morley
Original Assignee
Aventis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9727532.5A external-priority patent/GB9727532D0/en
Application filed by Aventis Pharma Ltd filed Critical Aventis Pharma Ltd
Application granted granted Critical
Publication of ATE289991T1 publication Critical patent/ATE289991T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT98962586T 1997-12-23 1998-12-23 Substituierte beta-alaninen ATE289991T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9727532.5A GB9727532D0 (en) 1997-12-23 1997-12-23 Chemical compounds
US9260298P 1998-07-13 1998-07-13
PCT/GB1998/003859 WO1999033789A1 (en) 1997-12-23 1998-12-23 SUBSTITUTED β-ALANINES

Publications (1)

Publication Number Publication Date
ATE289991T1 true ATE289991T1 (de) 2005-03-15

Family

ID=26312873

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962586T ATE289991T1 (de) 1997-12-23 1998-12-23 Substituierte beta-alaninen

Country Status (19)

Country Link
EP (1) EP1042279B1 (de)
JP (1) JP4555469B2 (de)
KR (1) KR20010033520A (de)
CN (1) CN1163477C (de)
AT (1) ATE289991T1 (de)
AU (1) AU747907B2 (de)
BR (1) BR9814376A (de)
CA (1) CA2316235A1 (de)
CZ (1) CZ20002342A3 (de)
DE (1) DE69829215T2 (de)
ES (1) ES2235383T3 (de)
HK (1) HK1034508A1 (de)
HU (1) HUP0101701A3 (de)
IL (1) IL136584A (de)
NO (1) NO20003273L (de)
NZ (1) NZ505363A (de)
SK (1) SK9372000A3 (de)
TR (1) TR200001947T2 (de)
WO (1) WO1999033789A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1294576A (zh) * 1998-01-23 2001-05-09 诺瓦提斯公司 Vla-4拮抗剂
WO2000039103A1 (en) * 1998-12-23 2000-07-06 Aventis Pharma Limited Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
BR0008280A (pt) * 1999-02-18 2001-11-06 Hoffmann La Roche Derivados de tioamida
BR0016818A (pt) 1999-12-28 2002-10-01 Pfizer Prod Inc Inibidores não-peptidila de adesão celular dependente de vla-4 úteis no tratamento de doenças inflamatórias, auto-imunes e respiratórias
DE10019755A1 (de) * 2000-04-20 2001-11-08 Bayer Ag Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten
FR2812633A1 (fr) * 2000-08-04 2002-02-08 Aventis Cropscience Sa Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides
GB2369357A (en) * 2000-10-09 2002-05-29 Bayer Ag Aliphatic, cyclic amino carboxylic acids as integrin antagonists
GB2367816A (en) 2000-10-09 2002-04-17 Bayer Ag Urea- and thiourea-containing derivatives of beta-amino acids
EP1330432A2 (de) * 2000-11-04 2003-07-30 Aventis Pharma Limited Substituierte alkansäuren
RU2290403C2 (ru) 2000-12-28 2006-12-27 Дайити Фармасьютикал Ко., Лтд. Ингибиторы vla-4
GB2377933A (en) 2001-07-06 2003-01-29 Bayer Ag Succinic acid derivatives useful as integrin antagonists
ES2382806T3 (es) 2003-07-24 2012-06-13 Daiichi Sankyo Company, Limited Compuesto ácido ciclohexanocarboxílico
EP1874283A4 (de) * 2005-04-28 2011-11-02 Ferring Bv Verwendung neuer verbindungen zur behandlung von ibd
EP1961750B1 (de) 2005-12-13 2013-09-18 Daiichi Sankyo Company, Limited Vla-4-hemmendes arzneimittel
AU2008219007A1 (en) 2007-02-20 2008-08-28 Merrimack Pharmaceuticals, Inc. Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306840B1 (en) * 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
PL186370B1 (pl) * 1995-08-30 2003-12-31 Searle & Co Związki, pochodne kwasu aminobenzoesowego, zawierające je kompozycje farmaceutyczne oraz zastosowanie tych związków
AU2337097A (en) * 1996-03-29 1997-10-22 G.D. Searle & Co. Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
AU2536097A (en) * 1996-03-29 1997-10-22 G.D. Searle & Co. Para-substituted phenylpropanoic acid derivatives as integrin antagonists
SK5462000A3 (en) * 1997-10-31 2001-02-12 Aventis Pharma Ltd Substituted anilides

Also Published As

Publication number Publication date
NO20003273D0 (no) 2000-06-22
TR200001947T2 (tr) 2001-01-22
JP2001527061A (ja) 2001-12-25
HUP0101701A2 (hu) 2001-11-28
CN1283181A (zh) 2001-02-07
KR20010033520A (ko) 2001-04-25
CN1163477C (zh) 2004-08-25
BR9814376A (pt) 2000-10-10
EP1042279A1 (de) 2000-10-11
NZ505363A (en) 2005-02-25
HK1034508A1 (en) 2001-10-26
ES2235383T3 (es) 2005-07-01
CZ20002342A3 (cs) 2001-11-14
AU1771999A (en) 1999-07-19
AU747907B2 (en) 2002-05-30
CA2316235A1 (en) 1999-07-08
DE69829215T2 (de) 2005-07-21
JP4555469B2 (ja) 2010-09-29
EP1042279B1 (de) 2005-03-02
NO20003273L (no) 2000-06-22
IL136584A0 (en) 2001-06-14
SK9372000A3 (en) 2002-03-05
DE69829215D1 (de) 2005-04-07
IL136584A (en) 2005-03-20
HUP0101701A3 (en) 2003-02-28
WO1999033789A1 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
ATE289991T1 (de) Substituierte beta-alaninen
DK1027328T3 (da) Substituerede anilider
ATE206611T1 (de) Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung
TR200102959T2 (tr) İntegrin antagonistleri olarak ikame edilmiş bisiklik heteroaril bileşikleri
HUP0204496A2 (en) Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same
IT1295694B1 (it) Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica
SE9604786D0 (sv) New compounds
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
DE60012048D1 (de) Phenoxypropanolamin-derivate, ihre herstellung und therapeutische verwendung
ZA953981B (en) New azolidinediones as antihyperglycemic agents
FR2712591B1 (fr) Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique.
CO4820432A1 (es) Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina
ATE165368T1 (de) Inhibitoren von testosteron-5-alpha reductase.
NO944892L (no) N-substituerte 3-azabicyklo (3.2.0) hepatanderivater som neuroleptika osv.
ATE126221T1 (de) Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung.
HUP0102025A2 (hu) Diaril-1,3,4-oxadiazolon-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69402935D1 (de) Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
PT89082A (pt) Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico
DE69902766D1 (de) N-aryloxyethylaminderivate zur behandlung der depression
EP0638564A4 (de) Benzothiazolsulfonamid-derivate, verfahren zu deren herstellung und anwendungen.
ATE245986T1 (de) Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen
NO950177L (no) Farmakologisk aktive erivater
MXPA02001861A (es) Nuevos inhbidores de la integrina alfav beta3.
EP1241166A4 (de) 3-mehtyl-chroman und -thiochromanderivate
PT850225E (pt) Intermediario para preparar um composto farmaceuticamente activo

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties